Search results for “Tumor associated antigen” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 2,818 patents, we discovered top 333 key players by total patent application. Immatics Biotechnologies GmbH, DRAGONFLY Therapeutics, Inc., Ganymed Pharmaceuticals AG are dominant in this area. They take 17.10% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 193
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 165
Ganymed Pharmaceuticals AG
Rheinland-Pfalz, Germany
Patent: 124
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 83
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 77
Bavarian Nordic A/S
Hovedstaden, Denmark
Patent: 65
Immunomedics, Inc.
New Jersey, United States
Patent: 62
Genentech, Inc.
California, United States
Patent: 61
Advaxis, Inc.
New Jersey, United States
Patent: 52
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 48
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 285 patents, we discovered top 20 start-ups by total patent application. DRAGONFLY Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, ALX Oncology, Inc. are active in this area.
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 165
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 23
STARTUP
ALX Oncology, Inc.
California, United States
Patent: 19
STARTUP
Systimmune, Inc.
Washington, United States
Patent: 16
STARTUP
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 15
STARTUP
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 8
STARTUP
Biomunex Pharmaceuticals
France
Patent: 8
STARTUP
AiVita Biomedical, Inc.
California, United States
Patent: 7
STARTUP
Bryologyx, Inc.
California, United States
Patent: 7
STARTUP
Phanes Therapeutics, Inc.
California, United States
Patent: 6
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,018 patents applied in the last 5 years. We discover 200 most active companies in this area. The fast-growing DRAGONFLY Therapeutics, Inc., Immatics Biotechnologies GmbH, F. Hoffmann-La Roche Ltd. take 27.80% of patent filing during this period.
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 165
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 73
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 45
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 26
Fred Hutchinson Cancer Research Center
Washington, United States
Patent: 26
Bavarian Nordic A/S
Hovedstaden, Denmark
Patent: 25
Novartis AG
Basel-Stadt, Switzerland
Patent: 22
Celgene Corp.
New Jersey, United States
Patent: 18
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 17
STARTUP
Systimmune, Inc.
Washington, United States
Patent: 16
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,018 patents in last 5 years, we discover 140 new entrants. DRAGONFLY Therapeutics, Inc., H. Lee Moffitt Cancer Center & Research Institute, Inc., Systimmune, Inc. are the most active new entrants in this area.
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 165
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 17
STARTUP
Systimmune, Inc.
Washington, United States
Patent: 16
Ampsource Biopharma Shanghai Inc.
Shanghai Shi, China
Patent: 16
Neuvogen, Inc.
California, United States
Patent: 15
STARTUP
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 15
The First Affiliated Hospital of Zhengzhou University
Henan Sheng, China
Patent: 14
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 11
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 11
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 10
Research Institutions
Order by:
Innovation Intensity
With the analysis among 696 patents, we discovered top 69 universities and scientific research institutions by total patent application. The Johannes Gutenberg University of Mainz, New York University, University of Zurich are dominant in this area. They take 19.68% of the total patent filing.
The Johannes Gutenberg University of Mainz
Rheinland-Pfalz, Germany
Patent: 35
New York University
New York, United States
Patent: 30
University of Zurich
ZURICH, Switzerland
Patent: 27
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 14
East Carolina University
North Carolina, United States
Patent: 12
University of Nebraska
Nebraska, United States
Patent: 11
University of Washington
Washington, United States
Patent: 9
École Polytechnique Fédérale de Lausanne
Vaud, Switzerland
Patent: 9
Texas Tech University System
Texas, United States
Patent: 9
Baylor College of Medicine
Texas, United States
Patent: 9
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: